Clinical Trials in Boston

Showing 3261-3280 of 15,299 trials

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)

NCT06489028

The aim of this clinical trial is to investigate the efficacy and safety of allo-APZ2-CVU, administered topically on therapy-resistant non-healing CVUs compared to placebo.

Venous Leg Ulcer

RHEACELL GmbH & Co. KG250 participantsStarted Dec 2024

Hialeah, Florida, United States • Miami, Florida, United States • Boston, Massachusetts, United States +12 more locations

Active Not RecruitingPhase 1< 1 mile

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

NCT03993873

A phase 1/2, first-in-human, open-label study of the safety, tolerability, PK, and efficacy of the novel MET/CSF1R/SRC inhibitor TPX-0022 in adult subjects with advanced or metastatic NSCLC, Gastric Cancer, or solid tumors harboring genetic alterations in MET. (SHIELD-I)

Advanced Solid TumorMetastatic Solid TumorsMET Gene Alterations

Turning Point Therapeutics, Inc.95 participantsStarted Sep 2019

La Jolla, California, United States • Orange, California, United States • Denver, Colorado, United States +21 more locations

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

Find Trials by Condition in Boston

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer

A Pilot Project to Facilitate Dental Care and Reduce Barriers For Youth With Disabilities

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Upper Limb Tremor Reduction in Essential Tremor Patients

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection

A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis